Sinopharm Group Co. Ltd. is a prominent player in the People's Republic of China's healthcare market, specializing in the wholesale and retail of pharmaceuticals, medical devices, and related health products. The company's business activities are organized across four main divisions. Its Pharmaceutical Distribution segment supplies pharmaceutical goods to a wide range of clients, including hospitals, fellow distributors, retail pharmacies, and clinics. This division additionally offers extensive distribution, logistics, and value-added support to both domestic and international manufacturers and suppliers in the pharmaceutical and healthcare sectors. The Medical Devices segment is solely focused on the distribution of various medical equipment. The "Other Business" segment is involved in the manufacturing and sale of pharmaceutical products, chemical reagents, and laboratory supplies. Beyond these core areas, the company also engages in property rental and management. It further distributes specialized items such as medical instruments, traditional Chinese herbal medicines, antibiotics, and biological products. Sinopharm provides a comprehensive array of services, including IT development, medicine and health consultations, investment services, import/export facilitation for goods and technology, various business and market information consulting, and the organization of conventions and exhibitions. Moreover, it oversees medical project investments, offers related consulting, and provides technological training. Notably, Sinopharm Group has established a strategic alliance with I-Mab to enhance its commercial capabilities and accelerate its market entry strategies. Founded in Shanghai, China, in 2003, Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.
The current price of SHTDY is $10.96 USD — it has increased by +2.24% in the past 24 hours. Watch Sinopharm Group stock price performance more closely on the chart.
What is Sinopharm Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Sinopharm Group stocks are traded under the ticker SHTDY.
Is Sinopharm Group stock price growing?▼
SHTDY stock has risen by +6.3% compared to the previous week, the month change is a +16.84% rise, over the last year Sinopharm Group has showed a -14.44% decrease.
What is Sinopharm Group market cap?▼
Today Sinopharm Group has the market capitalization of 34.2B
When is the next Sinopharm Group earnings date?▼
Sinopharm Group is going to release the next earnings report on March 19, 2027.
What were Sinopharm Group earnings last quarter?▼
SHTDY earnings for the last quarter are 0.16 USD per share, whereas the estimation was 0.16 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Sinopharm Group revenue for the last year?▼
Sinopharm Group revenue for the last year amounts to 81.26B USD.
What is Sinopharm Group net income for the last year?▼
SHTDY net income for the last year is 1.01B USD.
Does Sinopharm Group pay dividends?▼
Yes, SHTDY dividends are paid annual. The last dividend per share was 0.5 . As of today, Dividend Yield (FWD)% is 4.59%.
How many employees does Sinopharm Group have?▼
As of November 7, 2026, the company has 94,910 employees.
In which sector is Sinopharm Group located?▼
Sinopharm Group operates in the Health & Wellness sector.
When did Sinopharm Group complete a stock split?▼
Sinopharm Group has not had any recent stock splits.
Where is Sinopharm Group headquartered?▼
Sinopharm Group is headquartered in Shanghai, China.